Filter
818
Text search:
drug
prices
Featured
Recommendations
74
New Publications
247
Language
Document type
No document type
485
Studies & Reports
171
Guidelines
78
Strategic & Response Plan
36
Manuals
21
Situation Updates
8
Fact sheets
8
Training Material
4
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
Global
36
India
30
Kenya
28
Uganda
21
Myanmar / Burma
20
Western and Central Europe
17
Liberia
15
Nepal
15
Malawi
15
Zambia
14
South Africa
14
Ukraine
12
Sierra Leone
11
Nigeria
11
Ghana
11
Tanzania
11
Bangladesh
11
Latin America and the Carribbean
11
Zimbabwe
9
Africa
9
Ethiopia
8
Philippines
8
Syria
8
Indonesia
8
Namibia
8
Congo, Democratic Republic of
7
Botswana
7
South–East Asia Region
7
Cameroon
6
Mozambique
6
Asia
6
Eastern Europe
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Venezuela
3
Tajikistan
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Moldova
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Switzerland
1
Serbia
1
Colombia
1
Bolivia
1
Libya
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
316
Clinical Guidelines
80
Public Health
44
Pharmacy & Technologies
20
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
HIV
108
Mental Health
79
Pharmacy
56
TB
47
AMR
47
COVID-19
31
NCDs
19
Global Health Education
17
Health Financing Toolbox
17
Conflict
12
NTDs
11
Planetary Health
9
Malaria
9
Ebola & Marburg
8
Refugee
8
Disability
7
Caregiver
6
Polio
4
Natural Hazards
3
Rapid Response
3
Cholera
2
2.0 Rapid Response
1
Washington, D.C., USA, 23-27 September 2018
Provisional Agenda Item 4.6
CD56/10, Rev. 1 31 August 2018
Original: Spanish
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence of catastrophic health spending and impoverishing
...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di
...
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective
...
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate.
...
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo
...
What at first glance appears to be simple causality – climate change leading to more and more migration – has triggered intense academic debate over the past ten years because the circumstances are complex. There is need for a thorough analysis in the ground between denying the problem and asser
...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp
...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to
...
